US Code

Search

Search the current U.S. Code within Title 21

Search by citation or keyword across the current edition within Title 21.

20 results 379j-43
Scoped to Title 21
Exact match Title 21 Title 21 / Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter VII GENERAL AUTHORITY / Part C Fees / Subpart 7 fees relating to generic drugs / Section 379j–43

21 U.S.C. § 379j–43

Reauthorization; reporting requirements

Part C Fees / Subpart 7 fees relating to generic drugs

Exact citation match for 21 USC § 379J-43

Title 21 Title 21 / Section 379j–41

21 U.S.C. § 379j–41

Definitions

Part C Fees / Subpart 7 fees relating to generic drugs

Definitions

Title 21 Title 21 / Section 379d–3

21 U.S.C. § 379d–3

Streamlined hiring authority

Subchapter VII GENERAL AUTHORITY / Part A General Administrative Provisions

Streamlined hiring authority

Title 21 Title 21 / Section 301

21 U.S.C. § 301

Short title

Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter I SHORT TITLE

Short title

Title 21 Title 21 / Section 393

21 U.S.C. § 393

Food and Drug Administration

Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter X MISCELLANEOUS

Food and Drug Administration

Title 21 Title 21 / Section 379j

21 U.S.C. § 379j

Authority to assess and use device fees

Part C Fees / Subpart 3 fees relating to devices

Authority to assess and use device fees

Title 21 Title 21 / Section 352

21 U.S.C. § 352

Misbranded drugs and devices

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Misbranded drugs and devices

Title 21 Title 21 / Section 379i

21 U.S.C. § 379i

Definitions

Part C Fees / Subpart 3 fees relating to devices

Definitions

Title 21 Title 21 / Section 353

21 U.S.C. § 353

Exemptions and consideration for certain drugs, devices, and biological products

Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices

Exemptions and consideration for certain drugs, devices, and biological products

Title 21 Title 21 / Section 379j–1

21 U.S.C. § 379j–1

Reauthorization; reporting requirements

Part C Fees / Subpart 3 fees relating to devices

Reauthorization; reporting requirements

Title 21 Title 21 / Section 379j–11

21 U.S.C. § 379j–11

Definitions

Part C Fees / Subpart 4 fees relating to animal drugs

Definitions

Title 21 Title 21 / Section 379j–12

21 U.S.C. § 379j–12

Authority to assess and use animal drug fees

Part C Fees / Subpart 4 fees relating to animal drugs

Authority to assess and use animal drug fees

Title 21 Title 21 / Section 379j–13

21 U.S.C. § 379j–13

Reauthorization; reporting requirements

Part C Fees / Subpart 4 fees relating to animal drugs

Reauthorization; reporting requirements

Title 21 Title 21 / Section 379j–21

21 U.S.C. § 379j–21

Authority to assess and use generic new animal drug fees

Part C Fees / Subpart 5 fees relating to generic new animal drugs

Authority to assess and use generic new animal drug fees

Title 21 Title 21 / Section 379j–22

21 U.S.C. § 379j–22

Reauthorization; reporting requirements

Part C Fees / Subpart 5 fees relating to generic new animal drugs

Reauthorization; reporting requirements

Title 21 Title 21 / Section 379j–31

21 U.S.C. § 379j–31

Authority to collect and use fees

Part C Fees / Subpart 6 fees related to food

Authority to collect and use fees

Title 21 Title 21 / Section 379j–42

21 U.S.C. § 379j–42

Authority to assess and use human generic drug fees

Part C Fees / Subpart 7 fees relating to generic drugs

Authority to assess and use human generic drug fees

Title 21 Title 21 / Section 379j–51

21 U.S.C. § 379j–51

Definitions

Part C Fees / Subpart 8 fees relating to biosimilar biological products

Definitions

Title 21 Title 21 / Section 379j–52

21 U.S.C. § 379j–52

Authority to assess and use biosimilar biological product fees

Part C Fees / Subpart 8 fees relating to biosimilar biological products

Authority to assess and use biosimilar biological product fees

Title 21 Title 21 / Section 379j–53

21 U.S.C. § 379j–53

Reauthorization; reporting requirements

Part C Fees / Subpart 8 fees relating to biosimilar biological products

Reauthorization; reporting requirements